ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data

ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data

Immix Biopharma, Inc. (NASDAQ:IMMX)

Format

PNG

Quelle:

Immix Biopharma, Inc.

Downloads